VivArt-X is a medical technology spin-off from Eindhoven University of Technology, dedicated to developing advanced biomaterials for personalized regenerative solutions. Our mission is to redefine the standard of care in breast reconstruction: enabling predictable restoration, reconstruction, and regeneration of breast tissue with lasting results. Founded in 2022, VivArt-X has already gained broad recognition and multiple awards for its mission to restore confidence and redefine possibilities in regenerative medicine.
| Website | https://vivart-x.com/ |
| Employees | 8 (6 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Womens Health, Regenerative Medicine, Regenerative Materials, Biomaterials, Female Health Solutions, Biocompatible Materials, Regenerative Therapies, Tissue Engineering, Biotechnology, Therapeutic Materials, Advanced Biomaterials, Medical Devices, Innovative Materials, Scaffolding Materials, Material Science, Healthcare Technology, Drug Delivery Systems, Medical Innovation, Health Technology |
Looking for a particular VivArt-X employee's phone or email?
VivArt-X Questions
Dan Wu is the CEO and Co-Founder of VivArt-X.
6 people are employed at VivArt-X.
VivArt-X is based in Eindhoven, North Brabant.
Top VivArt-X Employees
-
Nick Beijer
Chief Operating Officer at VivArt-X
Utrecht, UT, NL2 -
Ymke Verspui
Research Assistant at VivArt-X
Eindhoven, NB, NL -
Jeroen van Asten
Research And Development Engineer at VivArt-X
Helmond, NB, NL1 -
Annika Vrehen
Senior scientist at VivArt-X
Netherlands -
Muhabbat K.
Senior Scientist at VivArt-X
Eindhoven, NB, NL
